Compare LC & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LC | TNDM |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2008 | 2013 |
| Metric | LC | TNDM |
|---|---|---|
| Price | $14.49 | $18.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 18 |
| Target Price | $22.67 | ★ $28.33 |
| AVG Volume (30 Days) | 1.4M | ★ 1.8M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.78 | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | $314,702,000.00 | ★ $1,014,736,000.00 |
| Revenue This Year | N/A | $8.01 |
| Revenue Next Year | $14.53 | $12.14 |
| P/E Ratio | $12.67 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $8.34 | $10.00 |
| 52 Week High | $21.67 | $29.65 |
| Indicator | LC | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 33.76 |
| Support Level | $13.36 | $17.71 |
| Resistance Level | $15.12 | $21.54 |
| Average True Range (ATR) | 0.60 | 1.30 |
| MACD | 0.16 | -0.61 |
| Stochastic Oscillator | 72.95 | 1.93 |
LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.